Anuh Pharma Ltd.
NSE: ANUHPHR BSE: ANUHPHR
NSE
76.00
0.42 (0.56%)
Prev Close
75.58
Open Price
76.8
Volume
20,499
Today Low / High
75.5 / 77.43
52 WK Low / High
69.27 / 114.9
Range
72 - 80
BSE
76.11
0.77 (1.02%)
Prev Close
75.34
Open Price
76.06
Volume
2,909
Today Low / High
75.09 / 76.7
52 WK Low / High
68 / 115
Range
72 - 80
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 76 (target range: 72 - 80), reflecting a change of 0.42 (0.5557%). On the BSE, it is listed at 76.11 (target range: 72 - 80), showing a change of 0.77 (1.02203%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
24 Feb
73.65
-0.22%
23 Feb
75.05
-1.84%
20 Feb
75.75
-0.84%
19 Feb
78.33
-3.03%
18 Feb
80.88
-4.17%
17 Feb
82.16
-0.56%
16 Feb
80.97
0.06%
13 Feb
81.40
-0.53%
12 Feb
82.95
-1.00%
11 Feb
84.19
-1.43%
10 Feb
83.51
0.11%
09 Feb
85.00
-2.38%
06 Feb
78.95
0.63%
05 Feb
82.78
-3.59%
04 Feb
79.43
3.11%
03 Feb
74.36
6.82%
02 Feb
74.20
-2.96%
01 Feb
75.00
-1.33%
30 Jan
72.00
1.32%
29 Jan
73.28
0.93%
28 Jan
72.19
1.25%
Anuh Pharma Ltd. Graph
Anuh Pharma Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Anuh Pharma Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 76.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 76.11 | 76.87 | 69.18 - 84.56 |
| 77.63 | 62.11 - 93.16 | ||
| 78.39 | 54.88 - 101.91 | ||
| Bearish Scenario | 76.11 | 75.35 | 67.81 - 82.88 |
| 74.59 | 59.67 - 89.51 | ||
| 73.83 | 51.68 - 95.97 |
Overview of Anuh Pharma Ltd.
ISIN
INE489G01022
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
39,999
Market Cap
7,360,450,560
Last Dividend
1.5
Official Website
IPO Date
2024-12-20
DCF Diff
-22.07
DCF
96
Financial Ratios Every Investor Needs
Stock Dividend of ANUHPHR
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-08-14 | August 14, 25 | 1.5 | 1.5 | 2025-08-15 | 2025-09-21 | |
| 2024-08-16 | August 16, 24 | 1.25 | 1.25 | 2024-08-16 | 2024-09-22 | |
| 2023-08-11 | August 11, 23 | 1 | 1 | 2023-08-11 | 2023-09-17 | |
| 2022-08-03 | August 03, 22 | 0.875 | 0.875 | 2022-08-04 | 2022-09-04 | |
| 2021-08-17 | August 17, 21 | 0.75 | 0.75 | 2021-08-18 | 2021-09-18 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 661.51 Cr | 499.37 Cr | 162.15 Cr | 0.2451 | 0.00 Cr | 2.56 Cr | 56.84 Cr | 47.35 Cr | 4.72 | 70.36 Cr | 0.0716 |
| 2024-03-31 | 647.00 Cr | 486.66 Cr | 160.34 Cr | 0.2478 | 0.00 Cr | 1.96 Cr | 67.67 Cr | 60.06 Cr | 5.99 | 87.25 Cr | 0.0928 |
| 2023-03-31 | 527.49 Cr | 401.48 Cr | 126.00 Cr | 0.2389 | 0.00 Cr | 1.47 Cr | 44.45 Cr | 36.18 Cr | 3.61 | 57.39 Cr | 0.0686 |
| 2022-03-31 | 486.65 Cr | 377.68 Cr | 108.97 Cr | 0.2239 | 0.00 Cr | 1.33 Cr | 37.20 Cr | 30.56 Cr | 3.05 | 52.04 Cr | 0.0628 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 19.56 Cr | 506.63 Cr | 180.60 Cr | 326.0248 Cr | 10.89 Cr | -8.67 Cr | 74.48 Cr | 60.38 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 178.5136 Cr |
| 2024-03-31 | 7.20 Cr | 445.68 Cr | 154.46 Cr | 291.2179 Cr | 2.69 Cr | -4.51 Cr | 75.40 Cr | 49.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 152.6938 Cr |
| 2023-03-31 | 1.93 Cr | 404.98 Cr | 163.76 Cr | 241.2212 Cr | 0.91 Cr | -1.02 Cr | 72.64 Cr | 53.25 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 161.3352 Cr |
| 2022-03-31 | 3.80 Cr | 347.17 Cr | 133.40 Cr | 213.7728 Cr | 4.22 Cr | 0.43 Cr | 79.92 Cr | 61.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 130.9058 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 37.1248 Cr | -19.9094 Cr | -4.8597 Cr | 16.9790 Cr | 12.3557 Cr | 19.5574 Cr | -20.1458 Cr | 61.0053 Cr | 8.4847 Cr | -12.5222 Cr | 0.9193 Cr |
| 2024-03-31 | 12.9251 Cr | 0.9182 Cr | -8.5684 Cr | 7.9085 Cr | 5.2749 Cr | 7.2017 Cr | -5.0166 Cr | 78.3098 Cr | 2.0134 Cr | -10.0254 Cr | -2.7639 Cr |
| 2023-03-31 | 53.9016 Cr | -43.4837 Cr | -12.2869 Cr | 52.3515 Cr | -1.8690 Cr | 1.9268 Cr | -1.5501 Cr | 47.4704 Cr | -3.1110 Cr | -8.7483 Cr | 7.2870 Cr |
| 2022-03-31 | 28.8637 Cr | -7.8171 Cr | -19.4492 Cr | 27.2489 Cr | 1.5974 Cr | 3.7958 Cr | -1.6148 Cr | 39.1220 Cr | -10.4867 Cr | -7.5577 Cr | 1.5025 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 197.18 Cr | 161.19 Cr | 35.99 Cr | 0.1825 | 13.80 Cr | 13.45 Cr | 1.34 | 20.91 Cr | 0.0682 |
| 2025-09-30 | 185.88 Cr | 144.53 Cr | 41.35 Cr | 0.2224 | 9.02 Cr | 7.61 Cr | 0.76 | 12.86 Cr | 0.0410 |
| 2025-06-30 | 186.48 Cr | 152.62 Cr | 33.86 Cr | 0.1816 | 7.78 Cr | 8.30 Cr | 0.83 | 13.68 Cr | 0.0445 |
| 2025-03-31 | 198.14 Cr | 148.46 Cr | 49.68 Cr | 0.2507 | 20.59 Cr | 12.46 Cr | 0.00 | 20.07 Cr | 0.0629 |
| 2024-12-31 | 159.51 Cr | 120.48 Cr | 39.04 Cr | 0.2447 | 12.61 Cr | 10.34 Cr | 1.03 | 15.73 Cr | 0.0648 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 1.94 Cr | 11.59 Cr | 13.53 Cr | 235.77 Cr | 118.21 Cr | 378.86 Cr | 61.64 Cr | 508.67 Cr | 181.74 Cr |
| 2025-03-31 | 19.56 Cr | 53.86 Cr | 73.41 Cr | 216.70 Cr | 74.48 Cr | 376.17 Cr | 60.38 Cr | 506.63 Cr | 180.60 Cr |
| 2024-09-30 | 2.97 Cr | 49.27 Cr | 52.24 Cr | 184.10 Cr | 71.10 Cr | 314.44 Cr | 47.63 Cr | 434.19 Cr | 131.08 Cr |
| 2024-03-31 | 7.20 Cr | 55.05 Cr | 62.26 Cr | 190.95 Cr | 75.40 Cr | 338.54 Cr | 49.24 Cr | 445.68 Cr | 154.46 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,764.20 | ₹4,232,906,754,074.00 | ₹1,200,910.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,395.50 | ₹1,697,804,303,390.00 | ₹348,437.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,418.90 | ₹1,495,556,554,816.00 | ₹359,909.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,306.50 | ₹1,087,750,340,235.00 | ₹2,296,180.00 |
| Lupin Limited | LUPIN | ₹2,292.20 | ₹1,047,633,964,600.00 | ₹1,104,211.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹919.65 | ₹925,383,088,904.00 | ₹564,412.00 |
| Mankind Pharma Limited | MANKIND | ₹2,155.70 | ₹889,883,893,710.00 | ₹802,349.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,211.50 | ₹703,641,166,265.00 | ₹3,039,172.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,625.00 | ₹672,553,125,000.00 | ₹231,439.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,085.00 | ₹588,388,686,765.00 | ₹455,450.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,076.35 | ₹581,074,632,036.00 | ₹2,096,370.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,524.50 | ₹386,772,080,341.00 | ₹102,371.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹3,021.30 | ₹377,468,000,791.00 | ₹185,671.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,085.90 | ₹334,844,408,201.00 | ₹172,351.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,430.80 | ₹271,240,390,232.00 | ₹90,076.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,377.10 | ₹223,767,965,930.00 | ₹212,770.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,869.00 | ₹221,725,000,000.00 | ₹2,566.00 |
| Eris Lifesciences Limited | ERIS | ₹1,380.20 | ₹188,006,552,958.00 | ₹30,161.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹978.20 | ₹175,205,274,834.00 | ₹5,721,405.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,331.00 | ₹171,035,250,259.00 | ₹27,190.00 |
| Granules India Limited | GRANULES | ₹599.95 | ₹145,589,096,164.00 | ₹775,187.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹739.90 | ₹145,437,055,448.00 | ₹143,343.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹897.35 | ₹142,113,093,368.00 | ₹305,229.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,727.00 | ₹131,272,198,992.00 | ₹21,410.00 |
| Cohance Lifesciences Limited | COHANCE | ₹310.50 | ₹118,787,096,970.00 | ₹467,931.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹907.55 | ₹111,389,056,800.00 | ₹41,715.00 |
| Viyash Scientific Limited | VIYASH | ₹219.27 | ₹95,646,792,922.00 | ₹684,479.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,136.00 | ₹85,254,425,952.00 | ₹7,919.00 |
| Strides Pharma Science Limited | STAR | ₹863.60 | ₹79,600,355,810.00 | ₹85,803.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹478.65 | ₹73,282,300,062.00 | ₹136,589.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹708.30 | ₹64,205,475,507.00 | ₹171,833.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹327.45 | ₹64,043,265,649.00 | ₹194,387.00 |
| FDC Limited | FDC | ₹364.30 | ₹59,311,713,601.00 | ₹46,671.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹130.92 | ₹42,486,366,301.00 | ₹619,172.00 |
| Innova Captab Limited | INNOVACAP | ₹668.35 | ₹38,246,281,297.00 | ₹12,022.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹316.30 | ₹34,465,713,320.00 | ₹32,182.00 |
| Suven Life Sciences Limited | SUVEN | ₹149.76 | ₹34,066,506,240.00 | ₹112,567.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹369.70 | ₹33,742,519,000.00 | ₹60,664.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹630.60 | ₹31,983,467,613.00 | ₹129,611.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,914.20 | ₹31,658,982,513.00 | ₹9,690.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹279.30 | ₹28,008,903,926.00 | ₹39,032.00 |
Key Executives
Assistant General Manager of Technical
Babu K. Moghaveera
Gender: male
Year Born:
Non-Executive Director
Bipin Nemchand Shah
Gender: male
Year Born: 1949
Chief Financial Officer
Darshan Dhirajlal Rampariya
Gender: male
Year Born:
Company Secretary & Compliance Officer
Manan Jayesh Vadhan
Gender: male
Year Born:
Joint MD & Executive Director
Ritesh Bipin Shah
Gender: male
Year Born: 1981
Chief Marketing Officer
Vinayak Shenoy
Gender: male
Year Born:
Joint MD & Executive Director
Vivek Bipin Shah
Gender: male
Year Born: 1986
FAQs about Anuh Pharma Ltd.
Who is the CEO of the company?
The CEO is Ritesh Bipin Shah.
What is the current market price of the stock?
The current price is ₹73.44.
What is the 52-week price range?
The range is ₹69.27-114.9.
What is the market capitalization of the company?
The market capitalization is ₹736.05 crores.
What is the dividend yield?
The dividend yield is 2.04%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 17.60.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Anuh Pharma Ltd. (ISIN: INE489G01022) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹736.05 crores and an average daily volume of 39,999 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹1.5.